ENDRA Life Sciences’ NASH Test Device, TAEUS, At Commercialization Inflection Point (NASDAQ:NDRA)

ENDRA Life Sciences’ NASH Test Device, TAEUS, At Commercialization Inflection Point (NASDAQ:NDRA)

Medical Equipment

ENDRA Life Sciences Inc. (NASDAQ:NDRA) recently announced it is moving forward with the commercialization of its Thermo Acoustic Enhanced UltraSound (TAEUS) device in Europe. The TAEUS device is essentially a point of care (POC) or field diagnostic hybrid of an ultrasound and MRI that can monitor the progression of one of the largest unmet medical needs worldwide.

Sourced through Scoop.it from: seekingalpha.com

Who We Are

Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.

Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.

Learn MoreOmnica Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *